We show that NanoString analysis is a very sensitive method (77, 78) to identify a distinct gene signature in skeletal muscle tissues of DM patients with anti‐TIF‐1γ or with anti‐Mi‐2 autoantibodies for diagnostic evaluation, cancer surveillance, and clinical follow‐up. This evidence concerns the gene TRIM33 and cancer.